• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/75

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

75 Cards in this Set

  • Front
  • Back
Alprostadil
a. Class: PGE1 analog
b. Therapeutic uses: keep a patent Ductus arteriosis or for ED (on nitrates can't use viagra)
c. Mechanisms: PGE1 analog, IV, topical, or subcutaneous
d. Side effects: NA
Epoprostenol
a. PGI2 analog
b. Treatment for pulmonary hypertension
c. Vasodilator and decreased platelet agg. via Gs
d. NEED CONTINUOUS IV infusion b/c half-life is 6min very expensive
Treprostinil
a. PGI2 analog (epoprostenol)
b. same as epoprostenol
c. same as epoprostenol
d. LONGER HALF LIFE
Latanoprost
a. PGF2 analog
b. Treatment for OPEN ANGLE GLAUCOMA
c. INCREASES outflow of aqueous humor, combination therapy with B blockers that decrease production of aq. humor
d. DARKENS IRIS COLOR and EYELASHES
Misoprostol
a. PGE1 analog
b. Used to PREVENT STOMACH ulcers in high risk patients taking NSAIDS, treat miscarriage - postpartum hemorrhage, abortion
c. Inhibits cAMP which increases mucin and decreases proton pump activity
d. ORAL administered, used to expel blastocyst post methotrexate (RU486) uterine contraction, cervix ripening
Dinoprostone
a. PGE2 analog
b. Contraction of pregnant uterus, abortion/postpartum hemorrhage, cervical ripening
c. PGE2 analog
d. Vaginal suppository
Carboprost
a. PGF2 analog (15 methyl PGF)
b. induces contraction of pregnant uterus (abortion, induced labor, hemorrhage)
c. IM injection
d. increases incidence of arrythmias (not commonly used)
Zafirlukast
a. LT inhibitor
b. Antagonizes smooth muscle contraction (relieves bronchoconstriction - asthma)
c. Competitive inhibitor of LT receptor type 1 ( PO BID - takes 3 d to start working, hepatic p450 metabolism)
d. Drug interaction with WARFARIN/PHENTANYL, GI complaints CHURG-STRAUSS synddrome (eiosinophilic granulomatosis - allergic granulomatosis)
Montelukast
a. LT inhibitor
b. relieves BRONCHOCONSTRICTION (asthma)
c. LT competitive inhibitor of LT receptor. PO (1 week max effect) - p450 and excreted in bile
d. OKAY in CHILDREN greater than 1 week - rare incidence of side effects
Zileuton
a. LT inhibitor
b. Asthama (bronchoconstriction reliefe), antiinflamatory (RA and IBD)
c. 5-lipoxygenase inhibitor, PO QID, few hours effective (renal excretion p450 metabolism)
d. HEPATITIS, drug interaction with WARFARIN, theophylline
Aspirin (acetylsalicyclic acid - ASA)
a. NSAID
b. inhibits platelet aggregation at LOW DOSE (thromboemoblism or atherosclerosis) and decreases PG mediated potentiation of pain (analgesia and antipyretic)
c. IRREVERSIBLE COX inhibitor, PO, ZERO ORDER
d. HEMORRHAGE, peptic ulcers, GI BLEEDING, aspirin sensitivity
Reyes Syndrome
Aspirin with viral infection AEs
Ibuprofen
a. NSAID (proprionic acids)
b. close patent ductus arteriosis, prototype aspirin
c. REVERSIBLE COX inhibitor
d. COMMON AEs but lower incidence of bleeding
Naproxen
a. NSAID (proprionic acid)
b. LONGER half life BID QD
c. REVERSIBLE COX inhibitor
d. common AEs but longer HALF LIFE
Common AEs of NSAIDS
Premature closing of DA
COMBOS of NSAIDS NOT SAFE
acute renal failure, interstitial nephritis
FLUID RETENTION
HEADACHE
TINNITUS
ULCERS
PRURITUS
Celecoxib
a. COX2 specific inhibitors
b. prevent the GI BLEEDS with NSAIDS
c. specifically inhibits COX2
d. LESS PEPTIC ULCERATION but increased risk of MI
Acetaminophen
a. Antipyretic analgesics
b. NOT ANTI-INFLAMMATORY or ANTIPLATELET (weak PG synth inhibitor) but for ANALGESIA and FEVER
c. inhibits COX3
d. TOXICITY - ACUTE hepatic failure, renal failure, pancreatitis CHRONIC nephropathy
SAFEST for KIDS (liquid)
OVERDOSE TX for ACETOMINOPHEN
USE N-acetylcysteine which WORKS as a substitute for HEPATIC GLUTATHIONE which promotes the METABOLISM (IV administer) of paracetamol (a toxic metabolite for acetaminophen)
ALSO MUCOMYST because it is used as a Mucolytic therapy
Indomethacin
a. NSAID
b. analgesic, antiinflam, antipyretic, USED for GOUT, close DA
c. REVERSIBLY inhibits COX and PLA2
d. common AEs for NSAIDs
Diclofenac Sodium
a. NSAID
b. arthritis, analgesia, fever
c. CONCENTRATES in SYNOLVIAL FLUID, reversible COX inhibitor
Keterolac
a. NSAID
b. analgesia, POST OP PAIN
c. COX inhibitor reversible
d. PO, IM, IV, or SC
Piroxicam
a. NSAID
b. USED for RA (analgesia, fever, antiinflam)
c. DECREASES PMN migration and lmpho activation COX INHIBITOR
d. Once DAILY ADMIN
Methotrexate
a. Disease Modifying AntiRheumatic Drug (immunosupressant - delays disease progression)
b. RA treatment, anti metabolite and immunosuppressant
c. BINDS dihydrofolate reductase - reduces folate and interferes with DE NOVO SYNTH OF THYMIDINE therfore inhibits DNA, RNA, and protein synth - INCREASES ADENOSINE RELASE decreases lymphocytes
d. LOW DOSE PO for RA and Psoriasis, HIGH DOSE for chemotherapy
NAUSEA, mucosal ulcers, bone marrow suppression and TERATOGEN HEPATOTOXICITY
Leflunomide
a. DMARD (nucleic acid inhib)
b. Immunosupressant for RA
c. Pyrimidine SYNTH inhibitor, reduces rUMP levels in LYMPHOCYTES blocks CELL CYCLE
d. RASH, bone marrow suppression, hepatotoxicity
Azathioprine
a. DMARD (MERCAPTOPURINE)
b. Immunosupressant (RA SEVERE or transplant, AUTOIMMUNE HEPATITIS)
c. converted to 6-mercaptopurin - INHIBITS PURINE SYNTH and SALVAGE pathway -
d. BONE MARROW SUPPRESSION, malignancy - ALLOPURINOL interactions, RISK of infection
Prednisone
a. CORTISOL analog (3x more potent than it)
b. Antiinflammatory, immunosuppressant (RA acute attacks only, ASTHMA, leukemia, HODGKIN LYMPHOMA, GOUT, PROPHYLAxIS for Transplant
c. Binds to the glucocorticoid receptor
d. reduces action of proinflammatory cytokines (AP1) induces expression of antiinflammatory genes (iKB) LYMPHOLYTIC
PO withe HEPATIC CONVERSION to ACTIVE
AE: adrenal insufficiency, HYPERGLYCEMIA, CATARACTS, ULCERS
Hydroxycloroquine
a. DMARD (RA and antimalaria)
b. UNK anti inflammatory, NOT SLOW PROGRESSION
c. TAKES 12-24 weeks to WORK NO BONE MARROW SUPPRESSION
d. AEs - retinopathy (rarere with chloroquine)
Sulfasalazine
a. DMARD (RA and IBD)
b. UNK anti inflammatory
c. AE - hypersensitive to SULFA ALLERGY
Anakinra
a. ANTI IL1B (prototype)
b. RA
c. RECEPTOR antagonist
d. AE same as ANT TNF - lymphoma or bad infection, SC injection
Rilonacept
a. Ankinra is prototype (ANTI IL1B)
b. SOLUBLE IL1B receptor (binds up IL1B)
Infliximab
a. DMARD - ANTI TNF antibody
b.RA and CHRON's
c. HUMANIZED monoclonal AB to TNF -single dose infusion
d. AE- infusion rxn -chest pain nausea fever dyspnea, HYPOTENSION, incre risk of infection LYMPHOMA
Adalimumab
a. DMARD, anti TNF ANTIBODY
b. RA, CHRONS, ANKYLOSING SPONDYLITIS, psoriatic arthritis
c. SC injection - humanized MONOCLONAL ANTIBODY against TNF
Etanercept
a. DMARD (refractory) - ANTI TNF
b. RA, ANkylosing spondylitis
c. SC 2x per week - FUSION protein- TNF Receptor ligand BINDING DOMAIN with an IgG Fc
Abatacept
a. DMARD (RA) - ETANERCEPT prototype
b. CTLA4 IG it is a recombinatn FUSION PROTEIN - inhibits the Cd28 - CD80/86 costimulation of TCELLS
c. IV infusion
Rituximab
a. ANTI NEOPLASTIC
b. RA and B CELL LYMPHOMA
c. ANTI CD20 monoclonal AB block B CELL COSTIMULATION (IV infusion)
d. AEs- hypersensitivity TUMOR LYSIS SYNDROME
Ondansetron
a. ANTIEMETIC
b. for MIGRAINES symptomss
c. BLOCKS 5-HT type 3 receptors
d. PO or IV - 3-4 hr halflife - AEs headache and diziness constapation
Sumatriptan
a. 5 HT1 receptor AGONIST (vasoconstrictor)
b. MIGRAINES
c. SC, PO, NASAL
d. AEs hypertension ISCHEMIA DRUG INTERAcTIONS with MAO-A inhibitors
Zolmitriptan
a. Sumatriptan is the PROTOTYPE
Ergotamine
a. 5 HT1 receptor AGONIST - VASOCONSTRICTOR - uterine STIMULANT and Alpha adrenergic ANTAGONIS
b.MIGRANES
c. RECEPTOR AGONIST
d. AEs: NAUSEA vomiting
CONTRA INDI for PERIPHERAL VASCULAR disease, CORONARY artery DISEASE or HYPERTENSION
Propranolol
a. BETA BLOCKER (prototype) attenuate the NERUOTRIGGER PHASE
b. MIgraines prophyl- decreases HR, Decreases LV contractility, REDUCES myocardial oxyg. demand
c. LOTS of AEs
Verampamil
a. Ca2+ channel ANTAGONIST (prototype) - decreases Ca2+ influx and dilates the vasculature
b. MIGRAINE prophylaxis - ATTENUATE NEUROTRIGGER AND VASOCONSTRICTIVE PHASE
c. PO and IV - bound plasma proteins
d. AEs EXCESSIVE VASODILATION, Bradycardia
Topiramate
a. Ca and Na channel blocker, GABA channel activator (Cl-) GLu receptor antagonist (AMPA and KAINATE but NOT NMDA)
b. Prophylaxis for MIGRAINES, also for SEIZURES
c. REnal excretion, AEs - dizziness, ataxia, fatigue, kidney stones
Amitriptyline
a. Tricyclic ANTI DEPRESSANT BLOCKS 5-HT reuptake (PROTOTYPE is imipramine)
b. ANti depressant and migraine prophylaxis
c. 4 weeks for efficacy - very lipid soluble large VD - bind plasma protein difficult to dialyze and get out - BLOCKS reuptake of 5HT
d. TOxicity - SEDATION tremor ANTICHOLINERGIC SIDE EFFECTS (DRY MOUTH, BLURRED VISION, urinary RETENTION)
Methysergide
a. 5-HT receptor ANTAGONIST/partiol agonist
b. migraine prophylaxis
c. vasoconstrictor and ERGOT DERIVATIVE
d. RETROPERITONEAL FIBROSIS
Colchicine
a. MT inhibitor - decreases NEUTRO migration into joint
b. SPECIFIC for GOUT and Prophylaxis
d. AEs include NAUSEA, diarrhea, vomiting and abdominal pain
Prednisone and indomethacin
Prednisone - cortisol analog and indomethacin is an NSAID -- GOUT and GOUT prophylaxis - AVOIDASA b/c compete with URATE secretion by KIDNEY and will RAISE SERUM URATE LEVELS
Allopurinol
a. Xanthine oxidase inhibitor (prototype)
b. DECREASES uric acid SYNTH (gout PROPHYLAXIS)
c. SUICIDE SUBSTRATE decreases synth of uric acid
d. AEs severe drug reaction with azathioprine
Febuxostat
a. Xanthine oxidase inhibitor
b. HYPERURICEMIA or GOUT
c. NON PURINE INHIBITOR
d. Better tolerated than allopurinol
Rasburicase
a. Urate oxidase (prototype)
b. recombinant urate oxidase enzyme from aspergillus converts urate into allantoin (more soluble) - for patients with TUMOR LYSIS SYNDROME NOT USED FOR GOUT
c. PREVENTS renal failure with massive loading of urate into serum from tumor lysis
d. AEs can only use ONCE b/c dev. AB against
Prednisone
a. Glucocorticoids - prototype
b. Prophylaxis immunosuppressive before transplant
c. Bind GR (displace HSP/immunophilin), Activates anti inflam gnes IKB and inhibiits Jun fos (AP1 pro inflamm genes)
Daclizumab
a. Immunosuppressant - humanized MURINE (CDR/humang IG1 chimeric monoclonal Ab)
b. Cd25 ab (ANTI IL2 receptor) - immunosupressant
c. IL2 binding, prevents activation of T cells
d. Prophylaxis for GRAFT REJECTION
Sirolimus (rapamycin)
a. Immunosuppressant (prototype)
b. organ transplant prophylaxis
c. inhibition of TOR protein kinase and signaling
d PO and rapid metabolism by P450 and excreted in BILE
DOSE DEPENDENT THROMBOCYTOPENIA and incr. infections NO RENAL TOXICITY ALONE, LEUKOPENIA
Mycophenolate mofetil
a. Immunosuppressant
b. ORgan transplant prophylaxis
c. Converted to Mycophenolic acid by plasma esterases- INHIBITS IMP - dehydrogenase - BLOCKS DE NOVO PURINE SYNTH important in lymphos - inhibits recruitment of leuks via blocking glycosylation of cell adhesion molecules (loss of GTP)
d.GI hematologic toxicity (incr risk of infections)
Azathioprine
a. immunosuppressant
b. converted to 6 mercaptorpurine, suppression of ORGAN rejections
c. HIGH INCIDENCE of malignancies and infections
Cyclosporine
a. DMARD (prototype)
b. RA (severe) and organ transplant and psoriasis atopic - chronic dry eyes
c. BINDS to cyclosporine inhibits NFAT and IL2 - signal transduction of TNFa and IL2 PO or IV
d AEs - nephrotoxicity and HYPERTENSION, infection, diabetes, DO NOT SUPRESS BONE MARROW
ACCELERATED clearance of cyclosporin (induce p450) with RIFAMPIN, phenobarbital, phenhytoin, methoxazole. DECREASED CL with erythomyacin, etc.
Tacrolimus (FK506)
a. immunosuppressant (prototype is cyclosporine)
b. 100X more potent same efficacy
c. BINDS FKBP same mech as cyclosporine inhibit calcineurin
d. PO or IV - ORGAN TRANSPLAT rescue - AEs inclue diabeteis neurologic toxicity, increased risk of malignancy, NEPHROTOXICITY
Enfuvirtide
a. viral FUSION INHIBITOR (not 1st line)
b. anti HIV
c. binds to gp41 prevents the hairpin unfolding that catalyzes fusion w/host cell
d. IV - called FUZEON
Ritonavir Boost
a. antiviral HIV PROTEASE inhibitor
b. HIV
c. mimics transition state during proteolysis of HIV recursors - inhibits the METABOLISM of protease inhibitors by inhibiting the CYP3A (boosting other protease inhibitors)
d. PO hepatic metabolism, fecal excretion - LIPODYSTROPHY, HYPERcholesterolemia drug ingteractions with P450 INHIBITION - multiple ddugs
Saquinavir
a. ANTI VIRAL HIV - PROTEASE inhibitor
b. HIV protease inhibitor
c. mimics transition state
d. SIMILAR as RITONAVIR - PO EXTENSIVE 1st PASS HEPATIC metabolism - CRYSTALIZES in KIDNEYS and LIVER - mUST DRINK LOTS oF WATER fewer side effects than ininavir
Nevirapine
a. nNRTIs
b.HIV childbirth anti viral
c. ALLOSTERIC RTI - combo with a NRTI to decrease resistance
d. RASH, hepatotoxicity
Efanvirenz
a. ANTI VIRAL nNRTI
b. HIV
c. SAME ase NEVIRAPINE
d. CNS effects dizziness insomina, hallucinations -- LONG HALF LIFE only 1x d dose
INDUCES CYP3A4 p450s (increase metabolism)
Maraviroc
a. Co receptor blocker - Prototype (not 1st line)
b. HIV
c. monoclonal Ab binds CCR5
Raltegavir
a. Integrase inhibitor
b. HIV
c. interefere with integration of viral DNA into HOST
Zidovudine (AZT)
a. antiviral NRTI
b. HIV
c. nucleoside RT inhibitor - PRODRUG - SUICIDE chain termination
d. PO - TOXIC, bone marrow supression, hepatotoxicity, CNS toxicity, renal excretion, GLUCURONIDATION metabolism
DRUG RESISTANCE - drug interactions with PROBENECID and INHIBITS liver METABOLYZING ENZYMES STAVUDINE competes with it for PHOSPHORYLATION
Lamivudine (3TC)
a. NRTI
b. HIV and HEP B
c. SAME MEcH as AZT and SYNERGIZES
d. dev of HEP B strains
Ematricitabine (FTC)
a. NRTI
b. HIV
c. SAME MECH as AZT
d. LOW SIDE EFFECTS
Tenofovir
a. NRTI
b. HIV and HEP B
c. PRO DRUG - disoproxil fumarate is converted to tenofovir - BLOCKS chain elongation - NO DIFFUSE OUT conc. are HIGH AMP analog
d. 1 day dose PO well absorbed AES include GI and PANCREATITIS lactic acid and renal insufficiency
Acyclovir
a. ANTIVIRAL for HERPES (HSV, conronic supress HSV and varicella)
c. INITIAL phospho via VIRAL THYMADINE KINASE then by host kinase - inhibits viral DNA polymerase (guan)
d. PO fair absorption (IV in serious cases) - RARE AE but nephrotoxicity and encephalopathy
Valacyclovir
a. antiviral (herpes zoster)
c. SAME MECH as acyclovir (L-valyl ester of acyclovir)
d. HAS MUCH BETTER ABSORBED than acyclovir since valyl ester of it
Ganciclovir
a. CMV anti viral
c. SAME as acyclovir
d. PO for chronic and IV for INTRAOCULAR IMPLANTS for RETINITIS
AE - myelosuppression (IV) , teratogen and CARCINOGENIC
Foscarnet
a. ANTIVIRAL (CMV and HIV)
c. NOT a PRODRUG - binds to PYROPHOSPHATE on viral DNA polymerase prevents its release inhibits activity
d. RENAL dysfunction, HYPOCALCEMIA, chromosomal damage, and bone marrow toxicity
Zanamivir
a. ANTI viral (INFLUENZA A&B)
C. inhibits NEURAMINIDASE (needed for maturation and release)
d. inhaled - AE - cough nasal throat pain, bronchospasm
Oseltamivir
a. ANti viral (inflenza)
c. SAME mech as Zanamivir (safer though)
d. PO
Pegylated INTERFERON ALPHA
a. ANTI VIRAL (HEP B and C and other viruses)
c. ACTivates RIbonuclease that degrades VIRAL mRNA (endogenous interpheron alpha is natural response) - INHIBITS protein synthesis elongation step of virally infected cells
d. pegylated - has LONGER HALFLIFE so given weekly SC or IM hepatic and renal metabolism - AES - FLU LIKE SYMPTOMS, psych problems, myelosuppression
Ribavirin
a. ANti viral (hep C and respiratory syncictial virus)
c. NUCLEOSIDE ANALOG prodrug - phosphorylated in CELL to active form inhibits viral RNA polymerase
d. INHALED FORMULATION for RSV penumonia in CHILDREN (take PO w/ interfereon alpha)
AES - TERATOGEN!!!! , MYELOSUPPRESSIOn (IV) and HEMOLYSIS